Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
0.00%
)
Bitcoin
78,153.96
(
-0.05%
)
News Focus
News Focus

Replies to post #244395 on Biotech Values

Replies to #244395 on Biotech Values
icon url

DewDiligence

11/02/22 4:38 PM

#244399 RE: dewophile #244395

ENTA is a great fit for GSK.

Many investors mistakenly think ENTA would be worth more to ABBV than to other suitors because of the Mavyret royalty stream, but such thinking is mathematically unsound (#msg-159261015).